Benign disease of uterus, Early uterine malignancy
Conditions
Interventions
Completion group:30 minutes before the end of the operation, parecoxib sodium was instilled by rapid intravenous infusion, the dose reduction of remifentanil was started, and oxycodone 0.1 mg/kg was i
Before skin incision:30 minutes before skin incision, parecoxib sodium was instilled by rapid intravenous drip, 5-10 minutes before skin incision, oxycodone 0.1 mg/kg was intravenously administered, a
Sponsors
Xuanwu Hospital of Capital Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. ASA classification I ~ II; 2. Aged 18~65 years old; 3. Elective laparoscopic hysterectomy under general anesthesia.
Exclusion criteria
Exclusion criteria: 1. The trial involves contraindications to drug use; 2. Patients who routinely use opioids; 3. Drug addicts; 4. Patients with alcoholism; 5. Patients with vertigo; 6. Long-term constipation patients; 7. Patients with esophageal reflux; 8. Patients with diabetic neuropathic pain.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of postoperative pain; | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of side effects;Additional dose of analgesic drugs;Postoperative outcomes;VAS score at critical time points; | — |
Countries
China
Contacts
Public ContactWang Tianlong
Miyun Hospital
Outcome results
None listed